Results 221 to 230 of about 2,165,213 (344)

A Novel Model of Patient Handover in Emergency Medicine-Addressing Hidden Tensions in Culture. [PDF]

open access: yesAEM Educ Train
Yiu SH   +6 more
europepmc   +1 more source

Discovery and Treatment of Action Potential‐Independent Myotonia in Hyperkalemic Periodic Paralysis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Hyperkalemic periodic paralysis (hyperKPP) is characterized by attacks of transient weakness. A subset of hyperKPP patients suffers from transient involuntary contraction of muscle (myotonia). The goal of this study was to determine mechanisms causing myotonia in hyperKPP.
Chris Dupont   +4 more
wiley   +1 more source

A model for the cognitive assessment of physicians. [PDF]

open access: yesFront Public Health
Del Bene VA   +10 more
europepmc   +1 more source

Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the utility of smartwatch and smartphone‐based activity metrics for assessing disease severity and quality of life in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Methods In the electronic monitoring of disease activity in patients with CIDP (EMDA‐CIDP) trial, we performed a prospective ...
Lars Masanneck   +15 more
wiley   +1 more source

Unsolicited Patient Complaints and Industry Payments for US Physicians.

open access: yesJAMA Netw Open
Park YH   +7 more
europepmc   +1 more source

The Impact of Administrative Burden on Academic Physicians: Results of a Hospital-Wide Physician Survey

open access: yesAcademic medicine : journal of the Association of American Medical Colleges, 2017
Sandhya K. Rao   +6 more
semanticscholar   +1 more source

Circulating Interleukin‐6 Levels and Timing of Acute Ischemic Stroke Onset

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Intravenous thrombolysis is the most widely available effective ischemic stroke treatment, but is approved only if given within 4.5 h from stroke onset. Many patients are not treated because stroke onset time is unknown. We evaluated the cytokine interleukin 6 (IL‐6) in circulating blood after acute ischemic stroke (AIS).
Robert G. Kowalski   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy